جست‌وجوی استاد و پژوهشگر

• Immunology
• Genomics
• Multiomics Analysis
• +۳ مورد دیگر

Calliope Dendrou is an Associate Professor in Clinical Pathology and Inflammation at the Kennedy Institute of Rheumatology (KIR), University of Oxford, leading the Immune Disease Multiomics Laboratory. She previously held a Wellcome & Royal Society Sir Henry Dale Fellowship at the University of Oxford’s Centre for Human Genetics before joining KIR in 2023. Her research focuses on immune disease mechanisms using multiomics approaches, including genomic profiling to identify therapeutic targets across tissues and immune-mediated diseases. She co-leads large-scale projects like the Oxford-J&J Cartography Consortium and the Chan Zuckerberg Initiative’s LEGACY Network, and teaches on the MSc in Genomic Medicine program. Educational Background: BSc (Biology, Imperial College London, 2005; Forbes Memorial Medal Winner); PhD in Infection & Immunity (University of Cambridge, 2010). Postdoctoral training at the Weatherall Institute of Molecular Medicine under Prof. Lars Fugger. Research interests include immunogenetics, cytokine signaling pathways, drug repositioning, and cross-disease pathophysiology. Her work integrates single-cell and spatial transcriptomics to dissect immune-cell interactions in diseases like rheumatoid arthritis, inflammatory bowel disease, and celiac disease. Recent articles highlight her contributions to understanding vaccine adjuvant responses, Th17 cell roles in spondyloarthritis, and immune-epithelial networks in celiac disease. Collaborations emphasize multi-omic data analysis (e.g., Panpipes pipeline) and translational studies toward precision medicine. Awards: Forbes Memorial Medal (BSc), Wellcome & Royal Society Sir Henry Dale Fellowship. Leadership roles include Equality, Diversity, and Inclusion Champion and 'Single-Cell & Spatial Omics for Precision Medicine' Module Lead. Lab & Teams: Immune Disease Multiomics Lab at KIR. Active in collaborative initiatives such as the LEGACY Network, focusing on large-scale immune profiling in ancestrally diverse populations.

• Gynecologic Oncology
• Women’s Health
• Cancer Treatment
• +۵ مورد دیگر

Dr. Laila Ingrid Muderspach is a Clinical Professor of Obstetrics & Gynecology at the University of Southern California (USC) on a part-time basis. She specializes in the diagnosis and treatment of gynecologic malignancies, emphasizing patient-centered care that addresses physical, emotional, and socioeconomic needs. Her clinical expertise spans surgical and medical interventions for cancers of the female reproductive system, with a focus on improving outcomes through advanced techniques like Enhanced Recovery After Surgery (ERAS) pathways and sentinel lymph node biopsies. Dr. Muderspach’s research spans epidemiological trends in gynecologic cancers, including adolescent and young adult (AYA) populations, and the optimization of surgical and chemotherapy protocols. She has contributed to pivotal studies on endometrial and cervical cancer staging, palliative care utilization, and the management of complications in vulvar cancer surgery. Her work also addresses healthcare disparities, such as accessibility to obstetric care and adherence to cancer treatment in underserved communities. Education: Medical degree from an unspecified institution, with training at USC and UCLA. Awards: Over 30 awards including Best Doctors recognition (2009–2014), National Faculty Award (2007), and multiple teaching accolades. Labs/Teams: Active in multidisciplinary gynecologic oncology teams at LAC+USC Medical Center, focusing on surgical innovation and patient safety. Her publications (over 150 listed) reflect a commitment to translational research, including clinical trials for novel therapies like eribulin for cervical cancer and investigations into HPV vaccine impact on cervical lesions.

Jørgen Arendt Jensenمشاهده پروفایل

استاد

• Medical Ultrasound
• Biomedical Signal Processing
• Digital Signal Processing
• +۴ مورد دیگر

Jørgen Arendt Jensen is a Professor of Biomedical Signal Processing at the Technical University of Denmark (DTU), with dual affiliations in the Department of Health Technology and the Department of Electrical Engineering (DTU Elektro). He leads the Center for Fast Ultrasound Imaging (CFU), a collaborative initiative involving DTU, BK Medical, Rigshospitalet, and DTU Nanotech. His research focuses on advanced medical ultrasound technologies, including synthetic aperture imaging, vector flow imaging, and ultrasound simulation, aiming to improve clinical image acquisition efficiency and accuracy. He teaches medical imaging courses and co-initiated the joint biomedical engineering program between DTU and the University of Copenhagen. Jensen’s work contributes to UN Sustainable Development Goals related to health and innovation. His research interests span algorithm development for fast ultrasound imaging, blood velocity characterization, and simulation of ultrasound systems. He supervises multiple PhD students and collaborates on projects involving transducer design, real-time imaging systems, and microvascular pathology analysis. Recent publications emphasize advancements in super-resolution ultrasound imaging, transducer optimization, and pressure gradient estimation. His lab, CFU, develops cutting-edge imaging solutions for clinical applications. Jensen’s contributions include patents on ultrasound imaging techniques and collaborative ventures to enhance diagnostic capabilities through interdisciplinary engineering.

Pingfu Fuمشاهده پروفایل

استاد

• Survival analysis
• Clinical trials
• Cancer research
• +۴ مورد دیگر

Pingfu Fu, PhD, is a Professor in the Department of Population and Quantitative Health Sciences at Case Western Reserve University's School of Medicine. He is also a member of the Developmental Therapeutics Program at the Case Comprehensive Cancer Center. His expertise spans biostatistics, mathematics, and computer science, with a focus on cancer research and HIV/AIDS. Dr. Fu advises researchers on study design and statistical methodology for clinical and pre-clinical studies. He teaches courses in survival data analysis and clinical trials, and was recognized as 'Professor of the Year' in 2010 by the Department of Epidemiology and Biostatistics. Education: PhD in Biostatistics (Case Western Reserve University, 2001), MS in Statistics (Case Western Reserve University, 1996), MS in Mathematics (Xiangtan University, 1988), and BS in Mathematics (Jiangxi Normal University, 1984). His research interests include survival analysis, tree-based methods, clinical trials, and statistical applications in medical research. He has co-authored numerous peer-reviewed articles, focusing on cancer disparities, radiomics, and computational pathology. Professional memberships include the American Statistical Association, American Mathematical Society, and American Cancer Society. Dr. Fu holds editorial roles at Reviews on Recent Clinical Trials , Journal of Clinical Oncology , and Journal of the National Cancer Center . His work has addressed mathematical challenges in stochastic processes and resolved statistical issues in study design and tree-based models. Notable contributions include developing risk prediction models for cancer outcomes and advancing interdisciplinary collaborations across oncology, biostatistics, and computer science. His lab focuses on integrating computational methods with clinical data to improve patient outcomes.

Andrew T Arndtمشاهده پروفایل

استادیار بالینی

• Thoracic Surgery
• Lung Cancer
• Chest Wall Tumors
• +۳ مورد دیگر

Andrew T Arndt, MD is a Clinical Assistant Professor in the Department of Surgery specializing in Thoracic Surgery at Northwestern University's Feinberg School of Medicine. Board certified by the American Board of Thoracic Surgery, he maintains clinical practice at Northwestern Medicine Central DuPage Hospital and holds active memberships in the Society of Thoracic Surgeons (2023-present) and American Board of Thoracic Surgery (2022-present). His research concentrates on advancing thoracic surgical oncology through investigations into lung cancer resection outcomes, chest wall tumor management, minimally invasive techniques, and pneumothorax recurrence factors. Current work emphasizes evidence-based risk stratification and surgical innovation to improve patient outcomes in complex thoracic pathologies. Recent publications demonstrate consistent focus on surgical registry analysis (2021), consensus development for thoracoscopic training (2021), systematic reviews of rare chest wall malignancies (2023), and identification of lifestyle-related recurrence risks (2021). This trajectory highlights growing contributions to thoracic surgical guidelines and evidence-based practice standards. Dr. Arndt serves as a consultant for Intuitive Surgical, Inc. (2024 disclosures) while maintaining active clinical and academic roles. No formal advisees or research grants are listed in current profile materials. Within Northwestern's Department of Surgery, he contributes to the Thoracic Surgery division's clinical and research missions, particularly in advancing minimally invasive approaches and multidisciplinary management of complex thoracic conditions through collaborative registry studies and consensus initiatives.

Ozan Seymen Sezenمشاهده پروفایل

دانشیار

• Rhinoplasty
• Facial Aesthetic and Plastic Surgery
• Snoring and Sleep Apnea Surgery
• +۳ مورد دیگر

Prof. Dr. Ozan Seymen Sezen is an Associate Professor specializing in Ear, Nose, and Throat (ENT) Diseases with dual affiliations at Istanbul Okan University Hospital since 2019 and Kartal Dr. Lütfi Kırdar Training and Research Hospital since 2001. He earned his medical degree from Istanbul University Cerrahpaşa Faculty of Medicine in 1993, completed his ENT specialization in 2000 after training at the University of Michigan Medical School, and achieved associate professorship status in 2012. His educational background includes: Master's Degree from Istanbul University Cerrahpaşa Faculty of Medicine Medical Specialization in ENT at SB Dr. Lütfi Kırdar Kartal Training and Research Hospital Associate Professorship in ENT at the same institution Prof. Sezen has developed specialized expertise in facial aesthetic and plastic surgery, particularly rhinoplasty, with additional focus on snoring and sleep apnea surgery, ear diseases and surgery, and sinus diseases and surgery. His clinical practice significantly exceeds typical volumes in endoscopic sinus surgery, sleep apnea procedures, rhinoplasty, and head and neck cancer surgeries. His research spans surgical innovations, pathological studies, and interdisciplinary connections between ENT and other medical specialties. His publication record demonstrates consistent scholarly contributions over two decades, with recent emphasis on sleep apnea treatment techniques, rhinoplasty innovations, and physiological impacts of ENT interventions. The research shows strong translational focus from laboratory studies to clinical applications. Key professional recognitions include: European Otorhinolaryngology Head and Neck Surgery Certificate of Competency (2012) Fellow of the European Board of Otorhinolaryngology Head and Neck Surgery As an educator, Prof. Sezen has continuously provided scientific, practical, and surgical training to resident doctors and medical students throughout his career. He has participated in over 20 national and international courses and congresses between 2010-2018, with specialized focus on facial plastic surgery techniques. His research collaborations span multiple institutions with emphasis on advancing ENT surgical practices through evidence-based approaches. Professional affiliations demonstrate his commitment to interdisciplinary collaboration, including membership in the Turkish Otorhinolaryngology Head and Neck Surgery Association, Facial Plastic Surgery Association, Turkish Sleep Research Association, European Academy of Facial Plastic Surgery, and American Academy of Cosmetic Surgery.

Rex Hungمشاهده پروفایل

دانشیار

• Bone and Soft Tissue Pathology
• Cardiovascular Pathology
• Pulmonary Pathology
• +۳ مورد دیگر

Rex Hung is an Associate Professor of Pathology at Harvard Medical School and serves as an Associate Pathologist at Massachusetts General Hospital . His academic career focuses on Bone and Soft Tissue Pathology , Cardiovascular Pathology , and Pulmonary Pathology , with significant contributions to cancer research.

Andrew Godwinمشاهده پروفایل

استاد

• Molecular Oncology
• Precision Medicine
• Biomarker Discovery
• +۳ مورد دیگر

Andrew Godwin is a Professor at the University of Kansas Medical Center , where he serves as the Chancellor’s Distinguished Chair in Biomedical Sciences and Director of Molecular Oncology in the Department of Pathology and Laboratory Medicine. He is also the Deputy Director of the NCI-designated University of Kansas Cancer Center and the Founding Director of the Kansas Institute for Precision Medicine and Biospecimen Shared Resource . Dr. Godwin is a leader in translational research and precision medicine , with a focus on molecular oncology , biomarker discovery , and genomic diagnostics . His work bridges basic and clinical science to improve cancer patient care, particularly in ovarian cancer , Ewing sarcoma , and breast cancer . He has contributed over 230 ovarian cancer-related publications and pioneered studies linking the PI3K/AKT pathway to cancer treatment targets. His research program encompasses liquid biopsies using extracellular vesicles , molecular therapeutics , companion diagnostics , and clinical trial validation . He leads the Biomarker Discovery Laboratory and has secured over $250M in extramural funding , including a $11.4M NIH grant for precision medicine initiatives. His team has developed CELLSEARCH® , the first FDA-cleared test for circulating tumor cells. Notable awards include the Dolph C. Simons, Sr. Higuchi Award (2020), Outstanding Mentorship in Pathology Award (2024), and multiple mentoring accolades from KU. He has mentored over 150 trainees across career stages and leads a multidisciplinary lab with expertise in genomics , proteomics , and bioengineering . Academic Roles: Chancellor’s Distinguished Chair in Biomedical Sciences Director, Molecular Oncology, Pathology and Laboratory Medicine Deputy Director, KU Cancer Center Founding Director, Kansas Institute for Precision Medicine Adjunct Professor, Bioengineering Program, University of Kansas Scientific Awards: KUMC Achievement Award for mentoring postdocs (2014) Chancellor’s Club Award for Research (2018) Dolph C. Simons, Sr. Higuchi Award (2020) KU Excellence in Mentoring Award (2021) Outstanding Mentorship in Pathology (2024) Key Research Themes: Extracellular vesicles as liquid biopsy tools Molecular mechanisms of sarcoma and breast cancer Genomic diagnostics and precision oncology Clinical trial biomarker validation Biospecimen repository leadership

Trenton R. Fosterمشاهده پروفایل

دانشیار

• Endocrine Surgery
• Thyroid Surgery
• Parathyroid Surgery
• +۷ مورد دیگر

Trenton R. Foster, M.D., is an Associate Professor of Surgery at Mayo Clinic College of Medicine, serving as a Consultant in the Division of Endocrine Surgery within the Department of Surgery. He holds multiple leadership positions including Associate Program Director for the General Surgery Residency Program and Associate Director of Student Clerkships Programs. Dr. Foster is also the Physician Lead for the Collaborative Endocrine Surgery Quality Improvement Program (CESQIP) and serves on several important committees including the Clinical Competency Committee and the Department of Surgery Equity, Inclusion, and Diversity Committee. Dr. Foster's research focuses on optimizing surgical management of endocrine disorders, with particular emphasis on determining appropriate surgical extent for thyroid cancer, improving preoperative localization for parathyroid disease, and refining diagnostic approaches for adrenal tumors. His work utilizes national and institutional databases to understand disease behavior and improve patient outcomes through evidence-based practice. Analysis of Dr. Foster's recent publications (2023-2025) reveals a strong focus on clinical outcomes research across the spectrum of endocrine surgery. His work addresses critical questions regarding optimal surgical approaches for thyroid, parathyroid, and adrenal conditions, with particular attention to minimally invasive techniques, long-term outcomes, and quality improvement initiatives. The research demonstrates expertise in analyzing complex surgical datasets to derive practical clinical insights that directly impact patient care. His scientific achievements include: 2025 Focused Practice Designation in Adult Complex Thyroid and Parathyroid Surgery from the American Board of Surgery 2019 Dennis Wasson, M.D. Award for Outstanding Graduating Chief Resident from Yale University Multiple research awards from 2015-2016 including the SVS Foundation Resident Research Prize and Department of Surgery Best Basic Science Research Award at Yale Golden Key National Honor Society membership during undergraduate studies Dr. Foster actively mentors residents and medical students through his roles in the General Surgery Residency Program and student clerkships. He collaborates extensively with colleagues in endocrinology, radiology, and pathology to provide comprehensive, multidisciplinary care for patients with endocrine disorders. His research directly informs clinical practice, leading to improved preoperative evaluation, optimized surgical approaches, and enhanced postoperative care protocols while maintaining safety and effectiveness.

Shweta Agarwalمشاهده پروفایل

استاد بالینی

• Pathology
• Head and Neck Pathology
• Cytopathology
• +۳ مورد دیگر

Shweta Agarwal is a board-certified clinical pathologist specializing in Head and Neck pathology and Cytopathology. Currently affiliated with Mayo Clinic in Jacksonville, Florida, she focuses on diagnosing salivary gland, thyroid, oral cavity, and sinonasal cancers. Her research integrates artificial intelligence for metastasis prediction and explores PD-L1 expression in rare tumors. 2018 Fellowship in Cytopathology - University of California San Francisco Medical Center 2017 Fellowship in Head and Neck Pathology - Massachusetts General Hospital 2016 Residency in Anatomic Pathology - University of Oklahoma Health Sciences Center 2011 Senior Residency in Oncopathology - Tate Memorial Hospital 2003 MBBS - GSVM Medical College, Kanpur University Her research bridges clinical pathology with computational tools, investigating salivary gland cancers, thyroid neoplasms, and oral squamous cell carcinoma. Key publications include AI-driven nodal metastasis predictions and PD-L1 analysis in rare cancers. Scientific awards include the 2025 Mayo Clinic 'Healing' recognition, 2022 Presidential Teaching Fellow nomination, and multiple best paper awards. She serves on committees for the College of American Pathologists and Papanicolaou Society of Cytopathology.

Vicente Valeroمشاهده پروفایل

استاد

• Breast Cancer
• Medical Oncology
• Inflammatory Breast Cancer
• +۳ مورد دیگر

Dr. Vicente Valero is a Professor and Deputy Chairman in the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center. He has been affiliated with MD Anderson since 1991, with expertise in breast cancer, particularly inflammatory breast cancer (IBC) and HER2-positive cancers. His academic credentials include an M.D. from Universidad Autonoma de Nuevo Leon, followed by postgraduate training in Internal Medicine at St. Elizabeth Hospital and Northeastern Ohio University College of Medicine, and fellowships in Hematology-Medical Oncology at the University of Cincinnati and The University of Texas Medical Branch in Galveston. Board-certified in Internal Medicine, Medical Oncology, and Hematology, Dr. Valero is a leading researcher in neoadjuvant therapies, molecular residual disease, and IBC treatment protocols. His research focuses on improving outcomes for metastatic breast cancer patients, optimizing surgical de-escalation strategies, and advancing immunotherapy and targeted therapies. He leads multiple clinical trials, including NRG-BR004 and NRG-BR003, and has authored over 150 peer-reviewed articles. Dr. Valero is recognized for his dedication to education, having received the Division of Medicine Teacher of the Year award twice and the Educator of the Month honor. He actively contributes to multidisciplinary quality assurance conferences and serves as a primary investigator for several funded research protocols. Key achievements include developing the R-IBC residual tumor burden calculator and pioneering studies on eliminating breast surgery for exceptional responders to systemic therapy. His work emphasizes translating research into clinical practice to enhance early detection, prevention, and treatment efficacy in breast cancer.

• Immunology
• Cancer Biology
• Inflammation
• +۳ مورد دیگر

Kazuki Sato is an Associate Research Scientist in the Department of Cell Biology at Yale School of Medicine. His research focuses on immune regulation, inflammation, and cancer biology with particular emphasis on the roles of immune receptors like DNAM-1 and TIGIT in tumor progression and regulatory T cell function. He has conducted studies on B cell biology, macrophage subpopulations, and the interplay between gut permeability and cardiovascular inflammation. Education: PhD from University of Tsukuba (2017), MS (2013), BA (2011). His work has been supported by awards including the Overseas Research Fellowship and Daiichi Sankyo Foundation of Life Science grant. He leads research in the Su Lab, investigating immune mechanisms in chronic inflammation and cancer. Key contributions include identifying marginal reticular cells' role in germinal center apoptosis clearance and developing protocols for isolating follicular dendritic cells. Research interests span immune checkpoint modulation, tumor immunology, and the gut-immune axis. His publications highlight translational insights into cytokine signaling pathways (e.g., IFN-γ, IL-6) and cellular interactions in inflammation-driven diseases.

• T cell immunology
• Immune tolerance
• Checkpoint inhibitor immunotherapy
• +۵ مورد دیگر

Martina Damo serves as Assistant Professor in the Department of Medicine, Section of Rheumatology at the University of Chicago School of Medicine, where she joined the faculty in October 2023. She leads a research laboratory investigating immune checkpoint receptors on T cells and their role in immunological tolerance, with particular focus on how checkpoint blockade immunotherapy causes immune-related adverse events (irAEs) in cancer patients. Her work aims to identify druggable tolerance pathways and develop bioengineered therapies for tolerance modulation. Dr. Damo's educational background includes: PhD in Bioengineering from Swiss Federal Institute of Technology in Lausanne (EPFL), 2016 Postdoctoral Fellowship in Immunobiology at Yale University, 2022 Instructor position at Yale University, 2023 Her research centers on T cell immunology in physiological and pathological contexts, with emphasis on peripheral tissue immunity. She investigates mechanisms of immune tolerance in skin and liver environments, neoantigen recognition by T cells, and the pathogenesis of irAEs following cancer immunotherapy. Her laboratory employs advanced techniques including clonal lineage tracing, mouse models of cancer and autoimmunity, and bioengineering approaches for therapeutic development. Analysis of her publication history (2011-2025) reveals an evolving research trajectory from foundational work in antigen-specific tolerance and gene therapy (2011-2015) to contemporary focus on T cell exhaustion, checkpoint biology, and cancer immunotherapy applications (2018-2025). Her most cited works involve CD8+ T cell dynamics in tumors and viral infections, with consistent emphasis on translational applications. Key thematic areas include T cell tolerance mechanisms, irAE pathogenesis, and bioengineered tolerance-inducing therapeutics. Dr. Damo actively mentors within her research laboratory and collaborates extensively with immunology researchers including Jeffrey Hubbell, Thomas Gajewski, and Melody Swartz. Her work has attracted significant attention with multiple publications exceeding 100 citations, substantial social media engagement (over 250 X posts), and patent references (23 patents citing her work). She maintains active research funding supporting her laboratory's investigations into T cell tolerance pathways. Her laboratory operates within the University of Chicago's immunology research ecosystem, collaborating with colleagues in the Department of Medicine including Maria-Luisa Alegre and James Curran. Current projects focus on developing targeted approaches to prevent irAEs while preserving anti-tumor efficacy of checkpoint inhibitors, leveraging her expertise in tissue-specific immune regulation.

Harrison W Linمشاهده پروفایل

دانشیار

• Otolaryngology
• Neurotology
• Hearing Research
• +۷ مورد دیگر

Harrison W Lin, MD is an Associate Professor in the Department of Otolaryngology-Head and Neck Surgery at the University of California, Irvine School of Medicine . He is a board-certified otolaryngologist with clinical expertise in hearing disorders, skull base surgery, and facial paralysis. Dr. Lin is a principal investigator at the UC Irvine Center for Hearing Research , focusing on translating basic science findings into clinical trials. Medical Education: Keck School of Medicine, University of Southern California Residency: Harvard Medical School Fellowship: UC San Diego School of Medicine Dr. Lin's research interests span hearing and balance disorders , neurotology , and skull base tumors . He investigates acoustic neuromas , meningiomas , cochlear implants , and facial nerve repair . His publications (over 50) focus on head and neck surgery , hearing loss , and ENT clinical case studies . Recent works include studies on sensorineural hearing loss , pediatric parapharyngeal tumors , and impact of dizziness on geriatric patients . Dr. Lin has received the Physicians of Excellence award from the Orange County Medical Association in 2019 and 2021-2023 . He leads clinical trials for auditory and vestibular disorders and contributes to medical education through pathology quiz case reports . As a principal investigator at the UC Irvine Center for Hearing Research , Dr. Lin's lab focuses on hearing restoration and balance disorder management . He also serves as a clinical mentor for otolaryngology trainees and contributes to pediatric ENT and head and neck oncology literature.

Dean Bryantمشاهده پروفایل

مدرس

• Computational Cancer Biology
• Hematology
• Genomics
• +۳ مورد دیگر

Dean Bryant is a Lecturer in Computational Cancer Biology at the University of Southampton. He holds a BSc (Hons) and PhD, and is a Fellow of the Higher Education Academy (FHEA). His research focuses on computational approaches to understanding cancer biology, particularly in hematological malignancies such as leukemia and lymphoma. He is affiliated with the Institute for Life Sciences and the Bioinformatics and Genomics research groups. Current research projects include the Early Cancer Research Initiative Network (ECRIN-M3) funded by Cancer Research UK and studies on SDH-deficient gastrointestinal stromal tumors. Dean supervises PhD students in Cancer Sciences and Biomedicine, and actively contributes to research on tumor immunoglobulin sequencing, genomic landscapes, and metabolic alterations in cancer. His academic background includes roles in bioinformatics and cancer genomics, with a strong emphasis on integrating computational methods with experimental biology. Dean collaborates with institutions such as Wessex Medical Research and maintains active research partnerships within Southampton’s academic community.